Promise Bio secures $8.3M in seed investment for immune-mediated diseases Post date December 21, 2024 ← Promise Bio raises $8.3 million in Seed funding for its precision medicine tool for diseases → AION Lab’s Promise Bio included in The 51 most disruptive startups of 2024